| Tumorigenic circulating tumor cells from xenograft mouse models of non-metastatic NSCLC patients reveal distinct single cell heterogeneity and drug responses KN Suvilesh, YI Nussbaum, V Radhakrishnan, Y Manjunath, DM Avella, ... Molecular Cancer 21 (1), 73, 2022 | 33 | 2022 |
| Targeting AKR1B10 by Drug Repurposing with Epalrestat Overcomes Chemoresistance in Non–Small Cell Lung Cancer Patient-Derived Tumor Organoids KN Suvilesh, Y Manjunath, YI Nussbaum, M Gadelkarim, M Raju, ... Clinical Cancer Research 30 (17), 3855-3867, 2024 | 8 | 2024 |
| Identifying genes and their interactions from pathway figures and text in biomedical articles F He, J Thompson, Z Mao, Y Ren, Y Nussbaum, O Kholod, D Shin, ... 2021 IEEE International Conference on Bioinformatics and Biomedicine (BIBM …, 2021 | 8 | 2021 |
| Current and prospective methods for assessing anti-tumor immunity in colorectal cancer YI Nussbaum, Y Manjunath, KN Suvilesh, WC Warren, CR Shyu, JT Kaifi, ... International journal of molecular sciences 22 (9), 4802, 2021 | 8 | 2021 |
| TBX21 methylation as a potential regulator of immune suppression in CMS1 subtype colorectal cancer Y Shen, YI Nussbaum, Y Manjunath, JJ Hummel, MA Ciorba, WC Warren, ... Cancers 14 (19), 4594, 2022 | 2 | 2022 |
| Analysis of tumor-associated macrophages' heterogeneity in colorectal cancer patients using single-cell RNA-seq data. YI Nussbaum, Y Manjunath, JT Kaifi, W Warren, JB Mitchem Journal of Clinical Oncology 40 (4_suppl), 146-146, 2022 | 1 | 2022 |
| Identifying gene expression programs in single-cell RNA-seq data using linear correlation explanation YI Nussbaum, KSMT Hossain, J Kaifi, WC Warren, CR Shyu, JB Mitchem Journal of Biomedical Informatics 154, 104644, 2024 | | 2024 |
| Colorectal Cancer-Associated Myofibroblasts Exhibit Enhanced Angiogenin Expression and Signaling via the PLXNB2 Receptor A Hu, YI Nussbaum, J Mitchem, J Yoo Journal of Surgical Research 296, 273-280, 2024 | | 2024 |
| Please let us know how this document benefits you. KN Suvilesh, Y Manjunath, YI Nussbaum, M Gadelkarim, M Raju, ... Clinical Cancer Research 30 (17), 3855-3867, 2024 | | 2024 |
| Patient-derived tumor organoids from resected non-small cell lung cancers for high-throughput response testing with approved and repurposed drugs KN Suvilesh, Y Manjunath, YI Nussbaum, M Gadelkarim, A Srivastava, ... bioRxiv, 2023.10. 18.562944, 2023 | | 2023 |
| Patient-derived organoids from surgically treated, localized non-small cell lung cancer as high-throughput drug testing platforms for conventional and repurposed drugs Y Manjunath, SK Nagaraj, YI Nussbaum, M Gadelkarim, ... Cancer Research 83 (7_Supplement), 205-205, 2023 | | 2023 |
| Abstract B57: Studying the role of OPN-CD44 interaction in colorectal cancer antitumor immunity suppression using scRNA-seq data YI Nussbaum, Y Manjunath, E Shumway, KT Jussuf, WC Warren, ... Cancer Immunology Research 10 (12_Supplement), B57-B57, 2022 | | 2022 |
| Xenograft models of non-metastatic non-small cell lung cancer reveals micrometastasis-associated single cell composition KN Suvilesh, YI Nussbaum, V Radhakrishnan, Y Manjunath, DM Avella, ... Cancer Research 82 (12_Supplement), 267-267, 2022 | | 2022 |
| Data from Targeting AKR1B10 by Drug Repurposing with Epalrestat Overcomes Chemoresistance in Non–Small Cell Lung Cancer Patient-Derived Tumor Organoids KN Suvilesh, Y Manjunath, YI Nussbaum, M Gadelkarim, M Raju, ... American Association for Cancer Research (AACR), 0 | | |